U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805811) titled 'Testing Heart Failure Resilience Intervention for Caregivers (HEROIC) in Advanced Heart Fai... Read More
U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804511) titled 'Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Diseas... Read More
U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804355) titled 'Evaluation of an Online Educational Child Injury Prevention Intervention' on Aug. 31. Brie... Read More
U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804888) titled 'Evaluation of the Effects of Injectable Platelet-Rich Fibrin and Hyaluronic Acid Treatments... Read More
U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07803718) titled 'Rotational Atherectomy and Drug-Coated Balloon Angioplasty With Embolic Protection for Supe... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvala... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Ver... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More